Profile picture

Doctor Yara Shhab

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)
Membership: HFA Member
Follow
Logo ESC

Contributor content

Cardiovascular safety profiles of proteasome inhibitors: an eudravigilance based disproportionality analysis
Presentation
Cardiovascular safety profiles of proteasome inhibitors: an eudravigilance based disproportionality analysis
Cardiac adverse event profiles of EGFR tyrosine kinase inhibitors: a disproportionality analysis using eudravigilance
Presentation
Cardiac adverse event profiles of EGFR tyrosine kinase inhibitors: a disproportionality analysis using eudravigilance
Class-level differences and within-class heterogeneity in heart failure reporting with immune checkpoint inhibitors: a WHO vigiaccess pharmacovigilance study
Presentation
Class-level differences and within-class heterogeneity in heart failure reporting with immune checkpoint inhibitors: a WHO vigiaccess pharmacovigilance study
Do sleep aids differ in cardiac safety? A comparative eudravigilance analysis of melatonin and zolpidem arrhythmia reports
Presentation
Do sleep aids differ in cardiac safety? A comparative eudravigilance analysis of melatonin and zolpidem arrhythmia reports
Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance
Presentation
Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance
Atrial fibrillation reporting with semaglutide versus tirzepatide in eudravigilance: a comparative disproportionality analysis
Presentation
Atrial fibrillation reporting with semaglutide versus tirzepatide in eudravigilance: a comparative disproportionality analysis

ESC 365 is supported by